Thymosin Alpha-1 5mg
Thymosin Alpha-1 is a thymic peptide that modulates immune function by enhancing T-cell maturation, NK cell activity, and dendritic cell function. Approved in over 35 countries as Zadaxin for hepatitis B and C treatment. Research demonstrates broad immunomodulatory effects, vaccine response enhancement, and potential antitumor activity.
Sequence
Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN
Market avg: $54.99 — save 42%
Volume pricing
Pay with USDC via Coinbase Commerce
Certificate of Analysis
Independently verified by Janoshik Analytical
Test ID
JAN-TA1-2026-001
Purity
99.1%
Method
HPLC-MS
Batch
TA1-2026-01A
Test Date
February 1, 2026
Identity
Confirmed
Endotoxin
<0.5 EU/mg
Storage Requirements
Lyophilized
2-8°C, protect from light
Reconstituted
2-8°C, use within 14 days
Approved in >35 countries as Zadaxin. Refrigerate.
Published Research
2 peer-reviewed studies
Thymosin alpha 1: a comprehensive review of the literature
Tuthill C, Rios I, McBeath R. — Expert Opinion on Biological Therapy, 2010
Comprehensive review of thymosin alpha-1 clinical applications and immunological mechanisms.
Clinical applications of thymosin alpha-1
Goldstein AL. — Expert Opinion on Biological Therapy, 2009
Review of clinical trials for hepatitis, cancer immunotherapy, and vaccine adjuvant applications.
Related Products
Research use only. All products are sold strictly for in-vitro research purposes only. Not for human consumption. Information provided references published research literature. No medical claims are made or implied.